Q3 2017 EPS Estimates for Molina Healthcare Inc Cut by Analyst (MOH)
Molina Healthcare Inc (NYSE:MOH) – Research analysts at Jefferies Group decreased their Q3 2017 earnings per share (EPS) estimates for Molina Healthcare in a note issued to investors on Wednesday. Jefferies Group analyst D. Windley now expects that the company will earn ($0.34) per share for the quarter, down from their prior estimate of $0.41. Jefferies Group currently has a “Hold” rating and a $72.00 price target on the stock. Jefferies Group also issued estimates for Molina Healthcare’s Q4 2017 earnings at ($0.30) EPS and FY2018 earnings at $2.91 EPS.
Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, August 2nd. The company reported ($0.01) EPS for the quarter, missing analysts’ consensus estimates of $0.86 by $0.87. The firm had revenue of $5 billion during the quarter, compared to analyst estimates of $4.88 billion. Molina Healthcare had a negative return on equity of 3.93% and a negative net margin of 1.07%. The company’s quarterly revenue was up 14.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.67 EPS. ILLEGAL ACTIVITY NOTICE: “Q3 2017 EPS Estimates for Molina Healthcare Inc Cut by Analyst (MOH)” was first reported by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark laws. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/08/07/q3-2017-eps-estimates-for-molina-healthcare-inc-cut-by-analyst-moh.html.
MOH has been the topic of a number of other research reports. Zacks Investment Research raised Molina Healthcare from a “hold” rating to a “buy” rating and set a $72.00 target price on the stock in a research report on Thursday, May 4th. ValuEngine lowered Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, July 11th. TheStreet raised Molina Healthcare from a “c” rating to a “b” rating in a research report on Tuesday, May 2nd. Bank of America Corporation boosted their price target on Molina Healthcare from $59.00 to $60.00 and gave the stock an “underperform” rating in a research report on Friday, July 14th. Finally, Wolfe Research started coverage on Molina Healthcare in a research report on Friday, May 5th. They set a “market perform” rating and a $69.00 price target on the stock. Five analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $60.75.
Shares of Molina Healthcare (NYSE MOH) opened at 59.80 on Monday. The company’s market cap is $3.35 billion. Molina Healthcare has a 12 month low of $42.56 and a 12 month high of $72.79. The firm’s 50-day moving average price is $69.82 and its 200-day moving average price is $58.86.
In related news, Director John C. Molina sold 21,277 shares of the business’s stock in a transaction that occurred on Tuesday, July 18th. The stock was sold at an average price of $70.53, for a total transaction of $1,500,666.81. Following the transaction, the director now directly owns 611,154 shares of the company’s stock, valued at approximately $43,104,691.62. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider William Dentino sold 66,000 shares of the business’s stock in a transaction that occurred on Thursday, July 6th. The stock was sold at an average price of $68.68, for a total value of $4,532,880.00. The disclosure for this sale can be found here. Insiders have sold a total of 187,384 shares of company stock worth $12,796,072 over the last three months. 6.20% of the stock is owned by insiders.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Point72 Asset Management L.P. raised its position in Molina Healthcare by 1,821.5% in the first quarter. Point72 Asset Management L.P. now owns 599,500 shares of the company’s stock worth $27,337,000 after buying an additional 568,300 shares during the last quarter. Acadian Asset Management LLC raised its position in Molina Healthcare by 6,812.6% in the second quarter. Acadian Asset Management LLC now owns 415,587 shares of the company’s stock worth $28,748,000 after buying an additional 409,575 shares during the last quarter. Redmile Group LLC raised its position in Molina Healthcare by 42.7% in the first quarter. Redmile Group LLC now owns 1,149,727 shares of the company’s stock worth $52,428,000 after buying an additional 344,181 shares during the last quarter. Dimensional Fund Advisors LP raised its position in Molina Healthcare by 12.8% in the first quarter. Dimensional Fund Advisors LP now owns 2,488,977 shares of the company’s stock worth $113,498,000 after buying an additional 282,144 shares during the last quarter. Finally, Victory Capital Management Inc. raised its position in Molina Healthcare by 20.0% in the first quarter. Victory Capital Management Inc. now owns 1,583,018 shares of the company’s stock worth $72,186,000 after buying an additional 263,892 shares during the last quarter. 93.79% of the stock is currently owned by institutional investors and hedge funds.
About Molina Healthcare
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.